N
Nader Moazami
Researcher at New York University
Publications - 267
Citations - 12685
Nader Moazami is an academic researcher from New York University. The author has contributed to research in topics: Transplantation & Ventricular assist device. The author has an hindex of 47, co-authored 234 publications receiving 11344 citations. Previous affiliations of Nader Moazami include Washington University in St. Louis & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.
David S. Feldman,Salpy V. Pamboukian,Jeffrey J. Teuteberg,Emma J. Birks,Katherine Lietz,Stephanie A. Moore,Jeffrey A. Morgan,Francisco A. Arabia,Mary E. Bauman,Hoger W. Buchholz,Mario Eng,Marc L. Dickstein,Aly El-Banayosy,Tonya Elliot,Daniel J. Goldstein,Kathleen L. Grady,Kylie Jones,K. Hryniewicz,Ranjit John,Annemarie Kaan,Shimon Kusne,Matthias Loebe,M. Patricia Massicotte,Nader Moazami,Paul Mohacsi,Martha L. Mooney,Thomas A. Nelson,Francis D. Pagani,William C. Perry,Evgenij V. Potapov,J. Eduardo Rame,Stuart D. Russell,Erik N. Sorensen,Benjamin Sun,Martin Strueber,Abeel A. Mangi,Michael Petty,Joseph G. Rogers,Amanda W. Rowe +38 more
TL;DR: Institutional Affiliations Co-chairs Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia Institute of Technology and Morehouse School of Medicine, and Pamboukian SV: University of Alabama at Birmingham, Birmingham, Alabama, Teuteberg JJ:University of Pittsburgh, Pittsburgh, Pennsylvania Task force chairs.
Journal ArticleDOI
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
Francis D. Pagani,Leslie W. Miller,Stuart D. Russell,Keith D. Aaronson,Ranjit John,Andrew J. Boyle,John V. Conte,Roberta C. Bogaev,Thomas E. MacGillivray,Yoshifumi Naka,Donna Mancini,H. Todd Massey,Leway Chen,Charles T. Klodell,Juan M. Aranda,Nader Moazami,Gregory A. Ewald,David J. Farrar,O. Howard Frazier +18 more
TL;DR: A continuous-flow LVAD provides effective hemodynamic support for at least 18 months in patients awaiting transplantation, with improved functional status and quality of life.
Journal ArticleDOI
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes
Robert L. Kormos,Jeffrey J. Teuteberg,Francis D. Pagani,Stuart D. Russell,Ranjit John,Leslie W. Miller,Todd Massey,Carmelo A. Milano,Nader Moazami,Kartik S. Sundareswaran,David J. Farrar +10 more
TL;DR: The incidence of right ventricular failure in patients with a HeartMate II ventricular assist device is comparable or less than that of patients with pulsatile-flow devices and might benefit from preoperative optimization of right heart function or planned biventricular support.
Journal ArticleDOI
Unexpected Abrupt Increase in Left Ventricular Assist Device Thrombosis
Randall C. Starling,Nader Moazami,Scott C. Silvestry,Gregory A. Ewald,Joseph G. Rogers,Carmelo A. Milano,J. Eduardo Rame,Michael A. Acker,Eugene H. Blackstone,John Ehrlinger,Lucy Thuita,Maria Mountis,Edward G. Soltesz,Bruce W. Lytle,Nicholas G. Smedira +14 more
TL;DR: The rate of pump thrombosis related to the use of the HeartMate II has been increasing at centers and is associated with substantial morbidity and mortality.
Journal ArticleDOI
An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
Samer S. Najjar,Mark S. Slaughter,Francis D. Pagani,Randall C. Starling,Edwin C. McGee,Peter Eckman,Antone Tatooles,Nader Moazami,Robert L. Kormos,David R. Hathaway,Kevin B. Najarian,Geetha Bhat,Keith D. Aaronson,Steven W. Boyce +13 more
TL;DR: Pump thrombus is a clinically important adverse event in patients receiving an HVAD, occurring at a rate of 0.08 events per patient-year, and this suggests that pump thrombosis event rates could be reduced through careful adherence to patient management guidelines.